Ami P. Vaidya, MD
Board Certifications: Gynecologic Oncology, Gynecology, Obstetrics, Pain care and Palliative care
Languages: English, Guajarati and Spanish
Locations: Hackensack, NJ
Dr. Ami P. Vaidya specializes in gynecologic oncology. She is the vice chair of the Department of Obstetrics and Gynecology; co-chief, Division of Gynecologic Oncology; and director of Robotics, Gynecology at Hackensack University Medical Center. She is a member of the Society of Gynecologic Oncologists and the American College of Obstetrics and Gynecology.
Education
Medical Education
Columbia University
Residency
New York University
Fellowship
Massachusetts General Hospital
Research Interests
Clinical research, advances in minimally invasive gynecologic surgery
Awards and honors
Honors/Awards
- Inside Jersey Top Doctors for Women’s Health: 2015, 2016, 2017, 2018
- Inside Jersey Top Doctors: 2014, 2015, 2016, 2017
- Inside Jersey Top Doctors for Cancer: 2014, 2015, 2016, 2017
- Jersey’s Best Magazine Top Doctors: 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2024
- Jersey’s Best – Top Doctors for Women’s Health: 2015, 2016, 2017, 2018, 2021, 2022, 2024
- Jersey’s Best – Top Doctors for Cancer: 2014, 2015, 2016, 2017, 2018, 2019, 2021, 2022
- New York Magazine: Top Doctors: 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022
- Top Doctors: New York Metro Area (book series): 17th Edition, 18th Edition
- Top Doctors New York Metro Area (digital guide): 2016, 2017, 2018, 2019, 2020, 2021, 2022
Memberships
Society of Gynecologic Oncologists and American College of Obstetrics and Gynecology
Hospital Affiliations
Hackensack University Medical Center
we are here for you
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.